4//SEC Filing
SETH SANDESH 4
Accession 0001213900-25-079019
CIK 0001388320other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 5:00 PM ET
Size
5.7 KB
Accession
0001213900-25-079019
Insider Transaction Report
Form 4
SETH SANDESH
Director
Transactions
- Tax Payment
Common Stock
2025-08-18$1.71/sh−120,900$206,739→ 184,481 total
Footnotes (1)
- [F1]Represents shares of common stock withheld to pay Mr. Seth's tax withholding obligations incurred in connection with the vesting of 300,000 restricted stock units, or RSUs, on August 18, 2025. On August 17, 2022, Mr. Seth was granted an award of 300,000 RSUs, in exchange for warrants granted to Mr. Seth on December 17, 2012 for services provided to the Company prior to becoming employed by Actinium. The warrants were in the money since vesting on December 17, 2013. Mr. Seth refrained from exercising the warrants to be aligned with the long-term interests of the Company and stockholders. In November 2018, the Board extended the expiration of Mr. Seth's warrants to February 2022. In February 2022, the Company requested that Mr. Seth not exercise the warrants. In exchange, the Board determined to grant Mr. Seth 300,000 RSUs based on the average fair value of the warrants during their vested life to continue to align Mr. Seth with the long-term interest of the Company and stockholders.
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeother
Related Parties
1- filerCIK 0001566175
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 5:00 PM ET
- Size
- 5.7 KB